Sign in

CIK 0000315545

  • Non-accelerated filer
  • Smaller reporting company

PROVECTUS BIOPHARMACEUTICALS, INC.

Sign in to watch
Ticker
PVCT
Exchange
OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
900031917
Phone
+1 866-594-5999
Business address
800 S. GAY STREET, SUITE 1610, KNOXVILLE, TN, 37929
Former names
PROVECTUS PHARMACEUTICALS INC, PROVECTUS PHARMACEUTICAL INC, ZAMAGE DIGITAL IMAGING INC, SPM GROUP INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2024-02-28 Raines Heather CFO Returned to the company · 8% Unsecured Convertible Promissory Note due 2022 −0 $50,000.00 $0
2024-02-27 Pershing Edward Director Grant or award · 8% Unsecured Convertible Promissory Note +0 $180,000.00 $0
2024-02-27 Pershing Edward Director Option exercise · 8% Unsecured Convertible Promissory Note −0
2024-02-27 Pershing Edward Director Option exercise · Series D-1 Convertible Preferred Stock +37,744 1,046,572
2024-02-17 Pershing Edward Director Option exercise · 8% Unsecured Convertible Promissory Note −0
2024-02-17 Pershing Edward Director Option exercise · Series D-1 Convertible Preferred Stock +47,180 1,008,828
2024-02-15 Pershing Edward Director Grant or award · 8% Unsecured Convertible Promissory Note +0 $75,000.00 $0
2024-02-02 Raines Heather CFO Returned to the company · 8% Unsecured Convertible Promissory Note due 2022 −0 $25,000.00 $0
2024-01-30 Pershing Edward Director Grant or award · 8% Unsecured Convertible Promissory Note +0 $135,000.00 $0
2024-01-26 Pershing Edward Director Option exercise · 8% Unsecured Convertible Promissory Note −0
2024-01-26 Pershing Edward Director Option exercise · Series D-1 Convertible Preferred Stock +47,180 961,648
2024-01-12 Pershing Edward Director Option exercise · 8% Unsecured Convertible Promissory Note −0
2024-01-12 Pershing Edward Director Option exercise · Series D-1 Convertible Preferred Stock +47,180 914,468
2023-12-28 Pershing Edward Director Grant or award · 8% Unsecured Convertible Promissory Note +0 $100,000.00 $0
2023-12-22 Pershing Edward Director Option exercise · 8% Unsecured Convertible Promissory Note −0
2023-12-22 Pershing Edward Director Option exercise · Series D-1 Convertible Preferred Stock +9,440 876,728
2023-12-19 Pershing Edward Director Option exercise · 8% Unsecured Convertible Promissory Note −0
2023-12-19 Pershing Edward Director Option exercise · Series D-1 Convertible Preferred Stock +37,760 867,288
2023-12-02 Pershing Edward Director Option exercise · 8% Unsecured Convertible Promissory Note −0
2023-12-02 Pershing Edward Director Option exercise · Series D-1 Convertible Preferred Stock +56,628 829,528

Page 9 of 17 · 329 trades